Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method

Heather J. Chalfin, Max Kates, Emma E. van der Toom, Stephanie Glavaris, James E. Verdone, Noah M. Hahn, Kenneth J. Pienta, Trinity J. Bivalacqua, Michael A. Gorin

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Objective: To investigate circulating tumor cells (CTCs) as biomarkers of urothelial carcinoma (UC). To date, the majority of work on this topic has utilized the CellSearch test, which has limited sensitivity due to reliance on positive selection for the cell surface protein epithelial cell adhesion molecule (EpCAM). We used a novel selection-free method to enumerate and characterize CTCs across a range of UC stages. Materials and Methods: Blood samples from 38 patients (9 controls, 8 nonmuscle invasive bladder cancer [NMIBC], 12 muscle-invasive bladder cancer [MIBC], and 9 metastatic UC) were processed with the AccuCyte-CyteFinder system. Slides were stained for the white blood cell markers CD45 and CD66b and the epithelial markers EpCAM and pancytokeratin. CTCs were defined as any cytokeratin postive and white blood cell marker negative cell. Separately, the more restrictive CellSearch definition was applied, with the additional requirement of EpCAM positivity. The Kruskal-Wallis ANOVA test compared CTC counts by stage. Results: Greater than or equal to 1 CTC was detected in 2 of 8 (25%) patients with NMIBC, 7 of 12 (58%) with MIBC, and 6of 9 (67%) with metastatic disease. No control had CTCs. Comparing CTC counts between groups, the only statistically significant comparison was between controls and patients with metastatic UC (P =.009). With EpCAM positivity as a CTC requirement, no CTCs were detected in any patient with NMIBC, and only 2 (17%) patients with MIBC had CTCs. CTCs tended to be larger in metastatic patients. Conclusion: CTCs were detected at all UC stages and exhibited phenotypic diversity of cell size and EpCAM expression. EpCAM negative CTCs that would be missed with the CellSearch test were detected in patients with NMIBC and patients with MIBC.

Original languageEnglish (US)
Pages (from-to)82-86
Number of pages5
StatePublished - May 2018

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method'. Together they form a unique fingerprint.

Cite this